产品名称
Atorvastatin calcium salt trihydrate, ≥98% (HPLC)
SMILES string
O=C(C1=C(C(C)C)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C2=CC=C(C=C2)F)=C1C3=CC=CC=C3)NC4=CC=CC=C4.[Ca+2].[3.0H2O]
InChI
1S/2C33H35FN2O5.Ca.3H2O/c2*1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;;;;/h2*3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);;3*1H2/q;;+2;;;/p-2/t2*26-,27-;;;;/m11..../s1
InChI key
SHZPNDRIDUBNMH-NIJVSVLQSA-L
assay
≥98% (HPLC)
form
powder
optical activity
[α]/D -9.0 to -5.0°, c = 0.5 in DMSO
storage condition
protect from light
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
room temp
Quality Level
Biochem/physiol Actions
β-Hydroxy β-methylglutaryl-CoA (HMG-CoA) reductase inhibitor.
Atorvastatin calcium salt trihydrate is a specific inhibitor of β-Hydroxy β-methylglutaryl-CoA (HMG-CoA) reductase. HMG-CoA reductase is the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, an early step in cholesterol biosynthesis. Atorvastatin is used in the treatment of hypercholesterolemia.
存储类别
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
target_organs
Liver
signalword
Warning
hcodes
Hazard Classifications
Aquatic Chronic 2 - STOT RE 2
B R Krause et al.
Atherosclerosis, 117(2), 237-244 (1995-10-01)
Since inhibitors of HMG-CoA reductase lower plasma triglycerides rather than cholesterol in rats, we compared the triglyceride-lowering activity of lovastatin in rats to that of atorvastatin, a more potent synthetic inhibitor, prior to evaluating these drugs in established animal models
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持
